Propofol Versus Dexmedetomidine for Sedation of Cancer Patients Undergoing ERCP
Status:
COMPLETED
Trial end date:
2024-02-01
Target enrollment:
Participant gender:
Summary
The aim of this study is to compare the efficacy and safety of propofol and dexmedetomidine during ERCP regarding hemodynamic, respiratory, sedative and cognitive functions.